TNF and cancer: There is evidence suggesting that urinary IL-2 levels as well as IL-6, IL-8, IL-12, TNF-α, and IFN-γ are promising markers in predicting BCG clinical responses (19, 22) suggesting cytokines as a potential treatment for cancer.